TEVA - Teva Pharmaceutical Industries Limited

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue22,385,00021,903,00019,652,000
Cost of Revenue11,560,00010,044,0008,296,000
Gross Profit10,825,00011,859,00011,356,000
Operating Expenses
Research Development1,848,0002,111,0001,525,000
Selling General and Administrative3,787,0004,376,0004,672,000
Non Recurring22,674,0003,218,0001,807,000
Others---
Total Operating Expenses---
Operating Income or Loss-17,484,0002,154,0003,352,000
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes-17,484,0002,154,0003,352,000
Interest Expense895,0001,330,0001,000,000
Income Before Tax-18,379,000824,0002,352,000
Income Tax Expense-1,933,000521,000634,000
Minority Interest1,386,0001,656,000158,000
Net Income From Continuing Ops-16,265,000329,0001,588,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-16,265,000329,0001,588,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-16,525,00068,0001,573,000